| Formulary Chapter 13: Skin - Full Chapter
|
| 13.09 |
Shampoos and other preparations for scalp and hair conditions |
|
|
Coal tar shampoo (Psoriderm®, Alphosyl 2 in 1®, Polytar®,)
|
Formulary
|
Shampoo 2.5%, Psoriderm® (distilled coal tar)
Shampoo 4%, Polytar® (coal tar solution)
Shampoo 5%, Alphosyl 2 in 1® (coal tar extract alcoholic)
 Patients should be advised to purchase over the counter- May be prescribed if appropriate to in-patients; patients should be advised on discharge that further supply should be purchased.
|
| 13.09 |
Androgenetic alopecia |
|
|
Eflornithine (Vaniqa®)
|
Non Formulary
|
Not to be prescribed for any indication on the NHS.
Removal of excessive hair (hirsutism) is not commissioned under the East Midlands Commissioning Policy for Cosmetic Procedures.
On the Nottinghamshire list of Medicines & Appliances of Limited Clinical Value that should never be prescribed.
|
Finasteride (Propecia®)
|
Non Formulary
|
Not prescribable under the NHS for the treatment of androgentic alopecia |
Minoxidil (Regaine®)
|
Non Formulary
|
Not prescribable under the NHS for the treatment of androgentic alopecia |
Other scalp preparations (Polytar Plus®)
|
Non Formulary
|
|
Shampoos (Ceanel Concentrate®)
|
Non Formulary
|
|
Key |
|
|
|
|
Cytotoxic Drug
|
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
| Status |
Description |
|
Grey / Non-Formulary: Medicines, which the Nottinghamshire APC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.
Grey / Non-Formulary (undergoing assessment): Work is ongoing and will be reviewed at a future APC meeting.
Grey / Non-Formulary (no formal assessment): APC has not formally reviewed this medicine or indication because it had never been requested for formulary inclusion. Often used for drugs new to market.
|
|
Medicines which should normally be prescribed by specialists only. eg hospital only.
For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.
|
|
Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised.
Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the Nottinghamshire APC.
|
|
Medicines suitable to be prescribed in primary care / general practice after specialist* recommendation or initiation.
A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust DTCs and approved by the Nottinghamshire APC.
*Specialist is defined by the APC as a clinician who has undertaken an appropriate formal qualification or recognised training programme within the described area of practice
|
|
Primary care/ non specialist may initiate as per APC guideline.
The supporting prescribing guideline must have been agreed by the relevant secondary care trust D&TC(s) and approved by the Nottinghamshire APC.
|
|
Medicines suitable for routine use within primary care.
Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing. |
|
|
|
|
